Scott D. Edmondson,Michael H. Fisher,Dooseop Kim,Malcolm Maccoss,Emma R. Parmee,Ann E. Weber,Jinyou Xu
申请号：
US15683007
公开号：
US20170348309A1
申请日:
2017.08.22
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
